CCA
BMY icon

Clearwater Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Clearwater Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-485
Closed -$31K – 227
2018
Q1 		$31K Buy
+485
New +$31.2K 0.01% 341

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearwater Capital Advisors's BMY Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 485 shares — an estimated $31K sold.

Clearwater Capital Advisors first reported a position in BMY in Q1 2018 and held it in 1 quarter. The position peaked at $31K in Q1 2018. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Clearwater Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Clearwater Capital Advisors sold 485 Bristol-Myers Squibb shares in Q2 2018, an estimated $31K.
  • Clearwater Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 1 quarter.
  • Clearwater Capital Advisors's Bristol-Myers Squibb position peaked at $31K in Q1 2018.
  • 1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.